Exact Mass: 659.2777406
Exact Mass Matches: 659.2777406
Found 73 metabolites which its exact mass value is equals to given mass value 659.2777406,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Pyridin-2-ylmethyl N-[(2S)-1-[[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-(1,3-thiazol-5-ylmethoxycarbonylamino)hexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate
Aripiprazole lauroxil
Beclabuvir
Carminomycin II
D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D004791 - Enzyme Inhibitors
Carminomycin II
D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D004791 - Enzyme Inhibitors
alpha-L-Rha-(1-2)-alpha-L-Rha-(1-3)-alpha-L-Rha-(1-3)-beta-D-GlcNAc|alphaLRha(1-2)alphaLRha(1-3)alphaLRha(1-3)betaDGlcNac
3,12-diacetyl-7-benzoyl-8-nicotinylingol
C37H41NO10 (659.2730326000001)
Glu Trp Tyr Tyr
Glu Tyr Trp Tyr
Glu Tyr Tyr Trp
Trp Glu Tyr Tyr
Trp Tyr Glu Tyr
Trp Tyr Tyr Glu
Tyr Glu Trp Tyr
Tyr Glu Tyr Trp
Tyr Trp Glu Tyr
Tyr Trp Tyr Glu
Tyr Tyr Glu Trp
Tyr Tyr Trp Glu
Aripiprazole lauroxil
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
Pramiconazole
C35H39F2N7O4 (659.3031437999999)
C254 - Anti-Infective Agent > C514 - Antifungal Agent
Fiboflapon sodium
C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent
Dobutamine lactobionate
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents
Valemetostat tosylate
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C156804 - EZH2 Inhibitor
Hydergine
C32H45N5O8S (659.2988690000001)
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D002491 - Central Nervous System Agents > D018697 - Nootropic Agents > D004877 - Ergoloid Mesylates D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
1,3-DI(N-Propyloxy-A-mannopyranosyl)-carbomyl 5-methyazido-benzene
2-O-sulfonato-alpha-D-glucopyranosyl 2-O-hexadecanoyl-alpha-D-glucopyranoside
alpha-L-Rhap-(1->3)-beta-D-GlcpNAc-(1->2)-alpha-L-Rhap-(1->2)-alpha-L-Rhap
6-deoxy-alpha-L-galactopyranosyl-(1->2)-6-deoxy-alpha-L-galactopyranosyl-(1->2)-6-deoxy-alpha-L-galactopyranosyl-(1->3)-2-(acetylamino)-2-deoxy-beta-D-glucopyranose
6-{[alpha-D-galactosyl-(1->3)-alpha-D-galactosyl-(1->4)-N-acetyl-D-glucosaminyl]oxy}hexanoic acid
alpha-L-Rhap-(1->2)-[beta-D-GlcpNAc-(1->3)]-alpha-L-Rhap-(1->3)-alpha-L-Rhap
6-[2-[(E,3E)-3-(4-tert-butyl-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1(17),2(7),4,8-tetraen-6-ylidene)prop-1-enyl]-3,3-dimethyl-5-sulfoindol-1-ium-1-yl]hexanoic acid
9,10-Dihydroergocornine methanesulfonate
C31H41N5O5. CH4SO3 (659.2988690000001)
4,13-bis(acetyloxy)-9-(benzoyloxy)-3,6,6,10,14-pentamethyl-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-8-yl pyridine-3-carboxylate
C37H41NO10 (659.2730326000001)
2-[(3-{[2,3-dihydroxy-5-(hydroxymethyl)-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohexyl]amino}-4,5,6-trihydroxycyclohex-1-en-1-yl)methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
3,12-diacetyl-7-benzoyl-8-nicotinoylingol
C37H41NO10 (659.2730326000001)
{"Ingredient_id": "HBIN006918","Ingredient_name": "3,12-diacetyl-7-benzoyl-8-nicotinoylingol","Alias": "NA","Ingredient_formula": "C37H41NO10","Ingredient_Smile": "CC1CC23C(=O)C(C(C4C(C4(C)C)C(C(C(=CC2(C1OC(=O)C)O3)C)OC(=O)C5=CC=CC=C5)OC(=O)C6=CN=CC=C6)OC(=O)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5325","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(2r,3s,4s,5s,6r)-2-{[(3r,4s,5r,6s)-3-{[(1r,2s,3r,4r,5r)-2,3-dihydroxy-5-(hydroxymethyl)-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohexyl]amino}-4,5,6-trihydroxycyclohex-1-en-1-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(1r,3r,4r,5r,7s,8s,9r,10e,12s,13s,14s)-4,13-bis(acetyloxy)-9-(benzoyloxy)-3,6,6,10,14-pentamethyl-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-8-yl pyridine-3-carboxylate
C37H41NO10 (659.2730326000001)
(2r,3r,4s,5s,6r)-2-{[(1s,2r,3r,4s,6s)-2,3-dihydroxy-6-(hydroxymethyl)-4-{[(1s,4s,5r,6r)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexyl]oxy}-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol
n-[(2r,3r,4r,5s,6r)-4-{[(2s,3r,4r,5s,6s)-4-{[(2s,3r,4r,5r,6s)-4,5-dihydroxy-6-methyl-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-2,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid
(1r,2r,6r,7s,8r,9s,12s)-12-(benzoyloxy)-2-hydroxy-7-(2-hydroxybenzoyloxy)-2,6,10,10-tetramethyl-5-oxo-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl 1-methyl-6-oxopyridine-3-carboxylate
(8s)-8-acetyl-10-{[(4s,5s,6s)-4-amino-5-[(3s)-3-hydroxy-1-{[(2r)-1-hydroxypropan-2-yl]oxy}butoxy]-6-methyloxan-2-yl]oxy}-1,6,8,11-tetrahydroxy-9,10-dihydro-7h-tetracene-5,12-dione
12-(benzoyloxy)-2-hydroxy-7-(2-hydroxybenzoyloxy)-2,6,10,10-tetramethyl-5-oxo-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl 1-methyl-6-oxopyridine-3-carboxylate
2-[(6-{[2,3-dihydroxy-6-(hydroxymethyl)-4-{[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexyl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3s,5s)-5-{[(1r,2r,3s,6r)-4-{[(1s,5r,6s)-5,6-dihydroxy-3-(hydroxymethyl)-4-{[(3s,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}cyclohex-2-en-1-yl]amino}-2,3-dihydroxy-6-(hydroxymethyl)cyclohexyl]oxy}-6-(hydroxymethyl)oxane-2,3,4-triol
2-{[2,3-dihydroxy-6-(hydroxymethyl)-4-{[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexyl]oxy}-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol
n-(4-{[4-({4,5-dihydroxy-6-methyl-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-2,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl)ethanimidic acid
(2r,3r,4s,5s,6s)-2-{[(2s,3s,4r,5r,6r)-6-{[(1r,2s,3s,4s,6r)-2,3-dihydroxy-6-(hydroxymethyl)-4-{[(1s,4s,5r,6r)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexyl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(8s)-8-acetyl-10-{[(4s,5s,6s)-4-amino-5-[(3s)-3-hydroxy-1-[(1-hydroxypropan-2-yl)oxy]butoxy]-6-methyloxan-2-yl]oxy}-1,6,8,11-tetrahydroxy-9,10-dihydro-7h-tetracene-5,12-dione
5-[(4-{[5,6-dihydroxy-3-(hydroxymethyl)-4-{[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}cyclohex-2-en-1-yl]amino}-2,3-dihydroxy-6-(hydroxymethyl)cyclohexyl)oxy]-6-(hydroxymethyl)oxane-2,3,4-triol
(1r,3r,4s,5r,7s,8s,9r,10e,12s,13s,14s)-4,13-bis(acetyloxy)-9-(benzoyloxy)-3,6,6,10,14-pentamethyl-2-oxo-16-oxatetracyclo[10.3.1.0¹,¹².0⁵,⁷]hexadec-10-en-8-yl pyridine-3-carboxylate
C37H41NO10 (659.2730326000001)